-
This study does not support the hypothesis that high calcium intake increases coronary artery calcification
-
A randomized, controlled trial showed that moderate doses of simvastatin or pravastatin resulted in reduced energy or exertional fatigue in up to 40% of patients, especially in women.
-
The FDA has approved a new drug with a novel mechanism of action for the treatment of rheumatoid arthritis in patients intolerant to or who have had inadequate response to methotrexate. Tofacifinib is an oral Janus kinase (JAK) inhibitor and is marketed by Pfizer as Xeljanz.
-
In this small pilot study of patients who sought help for insomnia, most of the awakenings were actually caused by sleep-disordered breathing.
-
-
-
Although the treatment of schizophrenia (SCH) involving psychological therapies and antipsychotic medications is typically done under the supervision of a psychiatrist, managing medical complications of the pharmacological interventions often falls on the primary care physician.
-
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports.
-
Acute bronchitis inflammation of the large airways presenting with cough is one of the most common diagnoses seen in primary care. Usually caused by viral infections, it is self-limited and antibiotics generally are not recommended.
-
A cross-sectional and longitudinal analysis of the impact of different activity levels on the risk of developing metabolic syndrome on a large random sample of the Danish population found that higher activity levels were associated with a decreased risk of developing metabolic syndrome over the 10-year follow-up period.